New clues to hepatitis B species restriction could help build a novel model for studying infection

Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to emerge in an advanced stage of disease that turns to fatal cirrhosis or liver cancer in nearly a million people every year. The development of effective treatments for HBV infectio